{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:45:50Z","timestamp":1791978350123,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ymgmr.2021.100801","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T12:08:16Z","timestamp":1632917296000},"page":"100801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Early treatment of biotin\u2013thiamine\u2013responsive basal ganglia disease improves the prognosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Dorota","family":"Wes\u00f3\u0142-Kucharska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Greczan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kaczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pajdowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Piekutowska-Abramczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Ciara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Halat-Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Jurkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Rokicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgmr.2021.100801_bb0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jimd.12125","article-title":"Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies","volume":"42","author":"Marc\u00e9-Grau","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10545-014-9712-9","article-title":"Defects of thiamine transport and metabolism","volume":"37","author":"Brown","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"pt 1","key":"10.1016\/j.ymgmr.2021.100801_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/awv342","article-title":"Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome","volume":"139","author":"Ortigoza-Escobar","year":"2016","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100801_bb0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14737175.2016.1187562","article-title":"Treatment of genetic defects of thiamine transport and metabolism","volume":"16","author":"Ortigoza-Escobar","year":"2016","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100801_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0037-1607191","article-title":"SLC19A3 gene defects sorting the phenotype and acronyms: review","volume":"49","author":"Alfadhel","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgmr.2021.100801_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-9-92","article-title":"Thiamine transporter-2 deficiency: outcome and treatment monitoring","volume":"9","author":"Ortigoza-Escobar","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100801_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.24953\/turkjped.2019.02.016","article-title":"Neonatal form of biotin-thiamine-responsive basal ganglia disease.\u00a0 Clues to diagnosis","volume":"61","author":"Degerliyurt","year":"2019","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","article-title":"Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone","volume":"19","author":"Tabarki","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100801_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01616412.2016.1263176","article-title":"Biotin\u2013thiamine\u2013responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment","volume":"39","author":"Algahtani","year":"2017","journal-title":"Yamada Neurol. Res."},{"issue":"171","key":"10.1016\/j.ymgmr.2021.100801_bb0055","article-title":"A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations","volume":"11","author":"K","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0028-1128152","article-title":"Biotin-responsive basal ganglia disease: case report and review of the literature","volume":"39","author":"El-Hajj","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgmr.2021.100801_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneurol.2009.293","article-title":"Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations","volume":"67","author":"Debs","year":"2010","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.ymgmr.2021.100801_bb0070","first-page":"1","article-title":"Biotin-thiamine-responsive basal ganglia disease: case report and follow-up of a patient with poor compliance","volume":"26","author":"Alabdulqader","year":"2018","journal-title":"Child Neurol. Open."},{"issue":"14(1)","key":"10.1016\/j.ymgmr.2021.100801_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12967-016-0930-9","article-title":"New perspective in diagnostics of mitochondrial disorders: two years\u2019 experience with whole-exome sequencing at a national paediatric Centre","volume":"12","author":"Pronicka","year":"2016","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.ymgmr.2021.100801_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1263","article-title":"The phenotype-driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes","volume":"8","author":"Jezela-Stanek","year":"2020","journal-title":"Mol Genet Genomic Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100801_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/fn.2017.68581","article-title":"Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease","volume":"55","author":"Pronicki","year":"2017","journal-title":"Folia Neuropathol."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100801_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24998","article-title":"Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors","volume":"82","author":"Ortigoza-Escobar","year":"2017","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ymgmr.2021.100801_bb0095","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/acn3.50898","article-title":"Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening","volume":"6","author":"Alfadhel","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100801_bb0100","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/ajmg.a.38189","article-title":"Biotin-thiamine responsive basal ganglia disease: identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generat","volume":"173","author":"Ferreira","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2021.100801_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bpa.12117","article-title":"Stressinduced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease","volume":"24","author":"Sch\u00e4nzer","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0110","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-2988","article-title":"Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency","volume":"131","author":"P\u00e9rez-Due\u00f1as","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100801_bb0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ejpn.2018.06.009","article-title":"Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?","volume":"22","author":"Kamasak","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awu130","article-title":"Reply: infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease","volume":"137","author":"van der Knaap","year":"2014","journal-title":"Brain"},{"issue":"Pt 7","key":"10.1016\/j.ymgmr.2021.100801_bb0125","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: a novel entity","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2021.100801_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2018.06.006","article-title":"Biotin-thiamine-responsive basal ganglia disease-a treatable metabolic disorder","volume":"87","author":"Mir","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejpn.2016.01.009","article-title":"Biotin and thiamine responsive basal ganglia disease \u2013 a vital differential diagnosis in infants with severe encephalopathy","volume":"20","author":"Ygberg","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100801_bb0140","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/brain\/awt054","article-title":"Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy","volume":"136","author":"Kevelam","year":"2013","journal-title":"Brain"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:25Z","timestamp":1762001485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S2214426921000951"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100801","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early treatment of biotin\u2013thiamine\u2013responsive basal ganglia disease improves the prognosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100801"}}